The Food and Drug Administration (FDA) has added 17 drug products to its list of essential medication exempted from the 12 ...
Dr. Matushansky joins as Immuneering plans to present updated data from Phase 2a trial of IMM-1-104 in pancreatic cancer in Q2 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback